To the Editor My coauthors and I recently undertook a review of the Original Investigation titled “Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial” published in the November 24, 2015, issue of JAMA.1 We found that incorrect data were reported for the baseline cohort in both eTables 11 and 12 in Supplement 1. In eTable 12, “Functional Outcome: Humphrey Visual Field Test-Mean Deviation,” the column headers were labeled incorrectly and the summary statistics for both HFA 30-2 and HFA 60-4 tests should have been presented in the original scale, instead of being weighted by the number of points in each test.
Glassman AR. Errors in Analysis of Mean Deviations in Study of Photocoagulation vs Ranibizumab for Diabetic Retinopathy. JAMA. 2019;321(10):1007–1008. doi:10.1001/jama.2019.0374
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: